- La Jolla Pharmaceutical Company stock price today and history
La Jolla Pharmaceutical Company (LJPC) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
La Jolla Pharmaceutical Company stock price
La Jolla Pharmaceutical Company latest news:
La Jolla stock jumps 16% after FDA approval
La Jolla Pharmaceutical Co. rose more than 16% Thursday afternoon after the company announced it had received approval for a new drug to increase blood pressure. The drug, Giapreza, is used to treat patients suffering from septic and other forms of shock, and La Jolla plans to make it available in March 2018 after getting the OK from the Food and Drug Administration. "We look forward to bringing this new treatment option to the many critically ill patients suffering from septic or other distributive shock," Chief Executive George Tidmarsh said in Thursday's announcement. La Jolla shares hit $33 in late trading after closing with a 4.5% gain at $28.30. Even before the after-hours bump, La Jolla shares had gained more than 61% this year, while the Dow Jones Industrial Average has increased 25.4% in that time.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
FDA approves La Jolla's low blood pressure drug
Dec 21 (Reuters) - La Jolla Pharmaceutical said on
Thursday the U.S. Food and Drug Administration had approved its
drug, Giapreza, to treat dangerously low blood pressure.
BRIEF-La Jolla Says FDA Approved Drug To Treat Critically Low Blood Pressure
La Jolla Pharmaceutical Co(LJPC): * U.S. FOOD AND DRUG ADMINISTRATION SAYS APPROVED GIAPREZA TO TREAT DANGEROUSLY LOW BLOOD PRESSURE. * U.S. FDA SAYS GRANTED THE APPROVAL OF GIAPREZA TO LA JOLLA PHARMACEUTICAL COMPANY.
Lake Shore Bancorp, Inc.LSBK
Lake Sunapee Bank GroupLSBG
Lakeland Bancorp, Inc.LBAI
Lakeland Financial CorporationLKFN
Lakeland Industries, Inc.LAKE
Lam Research CorporationLRCX
Lamar Advertising CompanyLAMR
Lancaster Colony CorporationLANC
Landmark Bancorp Inc.LARK